RNTX

Rein Therapeutics, Inc. Common Stock
RNTX

Overview Fund Activity

43 hedge funds and large institutions have $33.6M invested in Rein Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 9 closing their positions.

Holders
43
Holders Change
-4
Holders Change %
-8.51%
% of All Funds
0.76%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
5
Increased
11
Reduced
10
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VF
1
Virtu Financial
New York
$185K
2
William Blair & Company
2
William Blair & Company
Illinois
$819K
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$839K
4
JWA
4
JFS Wealth Advisors
Pennsylvania
$32K
5
GPFA
5
Game Plan Financial Advisors
Ohio
$130K

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$749K
2
Two Sigma Advisers
2
Two Sigma Advisers
New York
$0
3
GCP
3
GSA Capital Partners
United Kingdom
$0
4
BFM
4
Boothbay Fund Management
New York
$319K
5
KWM
5
Keebeck Wealth Management
Illinois
$78K
Name Holding Trade Value Shares
Change 		Shares
Change %
TRCT
51
Tower Research Capital (TRC)
New York
– -$3K -136 Closed
1 2
3